Fennec Pharmaceuticals Inc. (FENC)

Fennec Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 4, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	128	303	252	114	192	129
Market Cap Growth	-28.60%	20.14%	120.31%	-40.49%	48.91%	2.58%
Enterprise Value	116	316	247	95	159	114
Last Close Price	4.65	11.22	9.60	4.40	7.45	6.49
PE Ratio	48.69	-18.58	-10.64	-6.57	-9.75	-10.11
PS Ratio	2.56	14.25	164.24	-	1131.07	-
PB Ratio	-123.03	-26.06	-98.13	7.26	6.61	10.87
P/FCF Ratio	5.53	-17.67	-13.96	-8.05	-12.33	-14.25
P/OCF Ratio	5.53	-17.67	-13.96	-8.05	-12.33	-14.25
EV/Sales Ratio	2.38	14.88	160.94	-	935.98	-
EV/EBIT Ratio	19.81	-24.75	-10.94	-5.52	-8.90	-8.75
EV/FCF Ratio	5.05	-18.44	-13.68	-6.69	-10.20	-12.57
Debt / Equity Ratio	-23.42	-2.66	-9.69	0.32	-	-
Debt / FCF Ratio	1.38	-1.81	-1.38	-0.35	-	-
Asset Turnover	1.18	0.79	0.06	-	0.01	-
Inventory Turnover	1.21	0.92	-	-	-	-
Quick Ratio	7.14	2.92	5.49	12.76	12.93	6.01
Current Ratio	8.02	3.56	5.80	13.54	13.39	6.11
Return on Equity (ROE)	-	-	-359.22%	-77.36%	-88.46%	-76.99%
Return on Assets (ROA)	8.88%	-29.67%	-57.21%	-39.99%	-49.07%	-43.84%
Return on Capital (ROIC)	15.92%	-38.32%	-65.53%	-43.20%	-54.60%	-49.00%
Earnings Yield	2.14%	-5.30%	-9.41%	-15.16%	-9.42%	-9.89%
FCF Yield	18.07%	-5.66%	-7.16%	-12.43%	-8.11%	-7.02%
Buyback Yield / Dilution	-7.70%	-1.14%	-1.03%	-9.71%	-19.14%	-5.04%
Total Shareholder Return	-7.70%	-1.14%	-1.03%	-9.71%	-19.14%	-5.04%

Source: S&P Capital IQ. Standard template. Financial Sources.